These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


558 related items for PubMed ID: 33211209

  • 1. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL, Lin WC, Lin PY, Weng MY, Sun YT.
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
    Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, Teoh AKY, Webster S, Adelstein S, Corte TJ.
    Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
    [Abstract] [Full Text] [Related]

  • 9. Significance of myositis autoantibody in patients with idiopathic interstitial lung disease.
    Song JS, Hwang J, Cha HS, Jeong BH, Suh GY, Chung MP, Kang ES.
    Yonsei Med J; 2015 May; 56(3):676-83. PubMed ID: 25837172
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B.
    Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
    [Abstract] [Full Text] [Related]

  • 12. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F, Wang J, Zhang P, Zuo Y, Ye L, Wang G, Shu X.
    Front Immunol; 2022 Nov; 13():879266. PubMed ID: 35603153
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN, Pérez N, Braillard Poccard A, Gómez RA, Costi AC, García MA, Viola M, Benitez A, Aciar MM, Crespo Espíndola M, Yucra D, Cosatti MA, Pisoni C, Capelusnik D, Lojo MN, Barrios BI, Rivero M, Kisluk B, Granel A.
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A clinical analysis of risk factors for interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Cen X, Zuo C, Yang M, Yin G, Xie Q.
    Clin Dev Immunol; 2013 Nov; 2013():648570. PubMed ID: 24106519
    [Abstract] [Full Text] [Related]

  • 19. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
    Mecoli CA, Christopher-Stine L.
    Curr Rheumatol Rep; 2018 Apr 10; 20(5):27. PubMed ID: 29637383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.